[a
]Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of
Medical Sciences, Kerman, Iran
[b
]Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences,
Shiraz, Iran
[c
]Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine
and Science, Jacksonville, FL 32224, USA
[d
]Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran,
Iran
[e
]Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine,
Iran University of Medical Sciences, Tehran, Iran
[f
]Institute for Polymers, Composites and Biomaterials, National Research Council, IPCB-CNR,
Naples, Italy
[g
]Department of Chemical, Materials and Production Engineering, University of Naples
Federico II, Naples, Italy
[h
]Department of Bioengineering, University of California-Los Angeles, 410 Westwood Plaza,
Los Angeles, CA 90095, USA
[i
]Department of Biotechnology-Biomedicine, University of Barcelona, Barcelona 08028,
Spain
[j
]Department of Basic Science, Faculty of Veterinary Medicine, University of Tabriz,
Tabriz, Iran
[k
]Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of
Medical Sciences, Kerman, Iran
[l
]Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla,
Istanbul 34956, Turkey
[m
]Center of Excellence for Functional Surfaces and Interfaces (EFSUN), Faculty of Engineering
and Natural Sciences, Sabanci University, Tuzla, Istanbul 34956, Turkey
License:
Since January 2020 Elsevier has created a COVID-19 resource centre with free information
in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre
is hosted on Elsevier Connect, the company's public news and information website.
Elsevier hereby grants permission to make all its COVID-19-related research that is
available on the COVID-19 resource centre - including this research content - immediately
available in PubMed Central and other publicly funded repositories, such as the WHO
COVID database with rights for unrestricted research re-use and analyses in any form
or by any means with acknowledgement of the original source. These permissions are
granted for free by Elsevier for as long as the COVID-19 resource centre remains active.